123 related articles for article (PubMed ID: 38508363)
1. Evolutionary analysis of LMP-1 genetic diversity in EBV-associated nasopharyngeal carcinoma: Bioinformatic insights into oncogenic potential.
Alanazi AE; Alhumaidy AA; Almutairi H; Awadalla ME; Alkathiri A; Alarjani M; Aldawsari MA; Maniah K; Alahmadi RM; Alanazi BS; Eifan S; Alosaimi B
Infect Genet Evol; 2024 Jun; 120():105586. PubMed ID: 38508363
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
3. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
[TBL] [Abstract][Full Text] [Related]
4. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
5. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Santón A; Vidal AM; Bellas C
Acta Otolaryngol; 2003 Jun; 123(5):664-8. PubMed ID: 12875592
[TBL] [Abstract][Full Text] [Related]
6. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
See HS; Yap YY; Yip WK; Seow HF
World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
[TBL] [Abstract][Full Text] [Related]
12. Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.
Kwok H; Wu CW; Palser AL; Kellam P; Sham PC; Kwong DL; Chiang AK
J Virol; 2014 Sep; 88(18):10662-72. PubMed ID: 24991008
[TBL] [Abstract][Full Text] [Related]
13. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
14. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.
Chen JN; Zhou L; Qiu XM; Yang RH; Liang J; Pan YH; Li HF; Peng GR; Shao CK
J Med Microbiol; 2018 Nov; 67(11):1614-1627. PubMed ID: 30239329
[TBL] [Abstract][Full Text] [Related]
15. [Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.].
Smirnova KV; Senyuta NB; Lubenskaya AK; Dushenkina TE; Gurtsevich VE
Vopr Virusol; 2020; 65(2):77-86. PubMed ID: 32515563
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
17. Association Between
Lao TD; Le TAH
Genet Test Mol Biomarkers; 2019 Nov; 23(11):815-822. PubMed ID: 31693455
[No Abstract] [Full Text] [Related]
18. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
[TBL] [Abstract][Full Text] [Related]
19. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
